Status:
COMPLETED
Clinical Outcomes After AcrySof® ReStor IOL Surgery in Faculty Practice at UTSW Medical Center at Dallas: A Retrospective Review
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Outcomes Following Restor IOL Lens Implant
Eligibility:
All Genders
18-90 years
Brief Summary
To evaluate the clinical outcomes of AcrySof® ReSTOR® IOL for the Faculty Practice at UTSW Medical Center at Dallas
Detailed Description
The AcrySof® ReSTOR® intraocular lens (IOL) is the latest advance in vision surgery. This IOL has been uniquely designed to improve vision throughout the entire visual spectrum, up close, far away and...
Eligibility Criteria
Inclusion
- All patients of any race and sex between the ages of 18-90 years of age who have undergone ReSTOR® IOL cataract surgery will be recruited in this retrospective project.
Exclusion
- Patients who underwent conventional IOL cataract extraction surgery
Key Trial Info
Start Date :
March 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2007
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00344578
Start Date
March 1 2006
End Date
July 1 2007
Last Update
March 23 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Aston Ambulatory Care Center
Dallas, Texas, United States, 75390-8866
2
UTSW Medical Center at Dallas
Dallas, Texas, United States, 75390